FBLD 2008 Scientific Advisory Board

Eddy Arnold, Ph.D.

Eddy Arnold received his Ph.D. in Organic Chemistry from Cornell in 1982 with Jon Clardy and pursued postdoctoral studies with Michael Rossmann at Purdue. In 1987 Arnold established his research group at the Center for Biotechnology and Medicine (CABM) and Rutgers University, where he is Professor of Chemistry and Chemical Biology. Currently Arnold and his group are working to develop and apply structure-based drug and vaccine designs for treating and preventing serious human diseases, especially HIV/AIDS. Arnold and coworkers study the structure and function of reverse transcriptase (RT), an essential component of HIV and target of many of the most widely used anti-AIDS drugs. Another major effort in the laboratory, co-directed by Dr. Gail Ferstandig Arnold, consists of engineering a human common cold virus, rhinovirus, to display segments from more dangerous pathogens for the purpose of developing vaccines against AIDS and other infectious diseases. Arnold is a Fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology and is an NIH MERIT Award recipient.